A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Express Concerns
However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.
Some experts stated the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Service Response and Material Elimination
Based on TikTok, the platform has removed problematic content and banned related keywords and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at home.
After minutes of joining one group, a vendor shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, health issues or past usage.
Item Information and Pricing
Within these communities, posts display dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram said it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly serious health risks”.
